Home/Filings/4/0002019976-24-000014
4//SEC Filing

Novack Jeffrey Adam 4

Accession 0002019976-24-000014

CIK 0001217234other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 4:31 PM ET

Size

11.0 KB

Accession

0002019976-24-000014

Insider Transaction Report

Form 4
Period: 2024-11-18
Novack Jeffrey Adam
Secretary and General Counsel
Transactions
  • Sale

    Common Stock

    2024-11-18$22.00/sh807$17,754114,448 total
  • Sale

    Common Stock

    2024-11-18$22.00/sh1,071$23,562113,377 total
  • Sale

    Common Stock

    2024-11-18$21.65/sh3,656$79,161115,255 total
  • Sale

    Common Stock

    2024-11-25$24.00/sh365$8,760113,012 total
  • Sale

    Common Stock

    2024-11-25$24.00/sh858$20,592112,154 total
Footnotes (2)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.34 to $21.94, inclusive. The Reporting Person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Issuer

CareDx, Inc.

CIK 0001217234

Entity typeother

Related Parties

1
  • filerCIK 0002019976

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 4:31 PM ET
Size
11.0 KB